Holles Natalie C. 4

What Happened

• Natalie C. Holles, a director of LeonaBio, was granted a derivative award of 56,000 shares on 2026-05-05. The award is reported at $0.00 per share (no cash paid at grant). This is a grant/award (not a sale or open-market purchase) and represents compensation rather than an immediate market purchase.

Key Details

• Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (appears timely under Form 4 rules).
• Transaction type: Grant/Award (derivative) — 56,000 shares at $0.00.
• Vesting: Shares subject to the option vest monthly over 36 months on the monthly anniversaries of the grant date, contingent on continued service under the Issuer's 2026 Equity Incentive Plan (per footnote).
• Shares owned after transaction: Not specified in the provided filing details.
• No 10b5-1 plan, tax-withholding, or late filing flags noted in the supplied information.

Context

• This is a compensation-related award to a director that vests over time; it does not represent an immediate purchase or sale of tradable shares. Such awards are common for aligning directors with long-term shareholder value but do not, by themselves, signal short-term trading intent.